Immuron Limited (IMRN), an Australian biopharmaceutical company with a market capitalization of $13.5 million, has reported continued strong sales growth for its over-the-counter product Travelan.

In a move to enhance shareholder value, News Corp (NASDAQ:NWSA) has announced an update to its stock repurchase program, as ...

MELBOURNE, Australia and LIÈGE, Belgium, Jan. 17, 2025 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, Nasdaq: TLX, Telix, the Company) today announces that it has received a positive ...

The mining world will be altered drastically if whispers of a tie up between Rio Tinto and Glencore are true, with the two behemoths yet to break their silence. The talks were apparently brief and are ...

The current holdings of VSO directors.

See Upcoming Dividends for all ASX companies.

A deal aimed at capturing a bigger slice of the metals market, the proposed $160 billion merger of Rio Tinto a Glencore ...

A new offering to retail investors will open the door to the kind of high-risk strategies usually reserved for clients of ...

Banks and their shareholders reject the claim “wokeness” is stopping them lending to fossil fuel and forestry businesses, ...

The Australian sharemarket slipped on Friday, as a pullback by the major banks offset gains across most of the market.

Here comes the market “rotation”. Many traders are hoping that 2025 will see money from the pumped-up finance and tech sectors shift into an oversold resources sector.

Stockhead’s Road to 2025 video series highlights companies’ key 2024 achievements and the routes they’re plotting towards a successful year ahead.